The authors suggest that EPO administration may promote the growth of pituitary adenomas by enhancing angiogenesis through EPO-JAK2-STAT3-VEGF signaling pathway and should be used with caution in anemia patients bearing pituitary adenoma due to its potential deleterious effects (113). The gene discussed is VEGFA; the disease is pituitary gland adenoma.